Searchable abstracts of presentations at key conferences in endocrinology

ea0059apw2.2 | Metabolites as hormones | SFEBES2018

Short chain fatty acid signalling in human health and disease

Chambers Edward

Prospective studies and clinical trials have repeatedly demonstrated that high intake of dietary fibre reduces the incidence of metabolic diseases and their risk factors. An increased intake of dietary fibre raises the amount of undigested material available for fermentation by the gut microbiota and the production of short chain fatty acids (SCFA). SCFA have been shown to regulate energy homeostasis through various metabolic pathways and receptor-mediated mechanisms. The majo...

ea0053p01 | (1) | OU2018

The acute effects of propionate on resting energy expenditure and fat oxidation in healthy human volunteers

Aspey Karen , Chambers Edward , Frost Gary

Short chain fatty acids (SCFAs), including propionate, are the main metabolic by-products in the fermentation of non-digestible dietary fibre by the gut microbiota. SCFAs have wide-ranging effects in vivo, and their receptors, free fatty acid receptor 2 (FFAR2) and free fatty acid receptor 3 (FFAR3), are expressed at numerous tissue sites. Sodium propionate supplementation has been shown to increase energy expenditure, induce sympathetic neuron action potentials and p...

ea0065p175 | Metabolism and Obesity | SFEBES2019

The effect of tumour necrosis factor-alpha on myogenesis in immortalised human myoblasts

Frampton James , Chang Hanna , Chambers Edward , Murphy Kevin

Skeletal muscle exists in a state of continuous synthesis and breakdown of muscle proteins in order to preserve normal metabolic and locomotive functioning. Hormones are well established regulators of this homeostatic process. Chronic systemic inflammation can dysregulate skeletal muscle homeostasis via the disruption of endocrine signalling pathways. This can result in skeletal muscle atrophy, which is strongly implicated in the pathogenesis of type 2 diabetes and sarcopenia....

ea0050mte2 | Metabolomics and Diet | SFEBES2017

Modernazing dietary assessment by use of metabolic profiling

Garcia-Perez Isabel , Posma Joram M , Gibson Rachel , Chambers Edward S , Holmes Elaine , Frost Gary

A major limitation of nutritional science is the objective assessment of dietary intake in free-living populations. Monitoring individuals’ response to policy recommendations is based on self-reported dietary assessment tools, which are known to have high misreporting rates estimated at 30–88%. We have developed a novel analytical pipeline capable to classify people into consumers of a healthy or unhealthy diet based on urinary metabolic patterns, without relying on ...

ea0050mte2 | Metabolomics and Diet | SFEBES2017

Modernazing dietary assessment by use of metabolic profiling

Garcia-Perez Isabel , Posma Joram M , Gibson Rachel , Chambers Edward S , Holmes Elaine , Frost Gary

A major limitation of nutritional science is the objective assessment of dietary intake in free-living populations. Monitoring individuals’ response to policy recommendations is based on self-reported dietary assessment tools, which are known to have high misreporting rates estimated at 30–88%. We have developed a novel analytical pipeline capable to classify people into consumers of a healthy or unhealthy diet based on urinary metabolic patterns, without relying on ...

ea0031oc4.5 | Obesity, metabolism and bone | SFEBES2013

Energy intake following infusion of glucagon and GLP-1: a double-blind crossover study

Cegla Jaimini , Troke Rachel , Jones Ben , Tharakan George , McCullough Katherine , Wilde Julia , Lim Chung Thong , Parvizi Naseem , Hussein Mohamed , Minnion James , Cuenco Joyceline , Chambers Edward , Ghatei Mohammad , Tan Tricia , Bloom Stephen

Obesity is a growing global epidemic and current medical therapies have proven inadequate. Endogenous satiety hormones provide an attractive target for the development of drugs which aim to cause effective weight loss with minimal side effects. Two related peptide hormones, glucagon and glucagon-like peptide 1 (GLP-1), are the subject of this investigation. Both have been found to reduce appetite and cause weight loss. Additionally, glucagon increases energy expenditure. It is...